Profiling whole-tissue metabolic reprogramming during cutaneous poxvirus infection and clearance
IMPORTANCE: Human poxvirus infections have caused significant public health burdens both historically and recently during the unprecedented global Mpox virus outbreak. Although vaccinia virus (VACV) infection of mice is a commonly used model to explore the anti-poxvirus immune response, little is known about the metabolic changes that occur in vivo during infection. We hypothesized that the metabolome of VACV-infected skin would reflect the increased energetic requirements of both virus-infected cells and immune cells recruited to sites of infection. Therefore, we profiled whole VACV-infected skin using untargeted mass spectrometry to define the metabolome during infection, complementing these experiments with flow cytometry and transcriptomics. We identified specific metabolites, including nucleotides, itaconic acid, and glutamine, that were differentially expressed during VACV infection. Together, this study offers insight into both virus-specific and immune-mediated metabolic pathways that could contribute to the clearance of cutaneous poxvirus infection.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:97 |
---|---|
Enthalten in: |
Journal of virology - 97(2023), 12 vom: 21. Dez., Seite e0127223 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Pei, Luxin [VerfasserIn] |
---|
Links: |
---|
Themen: |
0RH81L854J |
---|
Anmerkungen: |
Date Completed 03.01.2024 Date Revised 03.01.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1128/jvi.01272-23 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM365011231 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM365011231 | ||
003 | DE-627 | ||
005 | 20240108141254.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1128/jvi.01272-23 |2 doi | |
028 | 5 | 2 | |a pubmed24n1247.xml |
035 | |a (DE-627)NLM365011231 | ||
035 | |a (NLM)38009914 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Pei, Luxin |e verfasserin |4 aut | |
245 | 1 | 0 | |a Profiling whole-tissue metabolic reprogramming during cutaneous poxvirus infection and clearance |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 03.01.2024 | ||
500 | |a Date Revised 03.01.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a IMPORTANCE: Human poxvirus infections have caused significant public health burdens both historically and recently during the unprecedented global Mpox virus outbreak. Although vaccinia virus (VACV) infection of mice is a commonly used model to explore the anti-poxvirus immune response, little is known about the metabolic changes that occur in vivo during infection. We hypothesized that the metabolome of VACV-infected skin would reflect the increased energetic requirements of both virus-infected cells and immune cells recruited to sites of infection. Therefore, we profiled whole VACV-infected skin using untargeted mass spectrometry to define the metabolome during infection, complementing these experiments with flow cytometry and transcriptomics. We identified specific metabolites, including nucleotides, itaconic acid, and glutamine, that were differentially expressed during VACV infection. Together, this study offers insight into both virus-specific and immune-mediated metabolic pathways that could contribute to the clearance of cutaneous poxvirus infection | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a immune response | |
650 | 4 | |a metabolism | |
650 | 4 | |a poxvirus | |
650 | 7 | |a Glutamine |2 NLM | |
650 | 7 | |a 0RH81L854J |2 NLM | |
650 | 7 | |a itaconic acid |2 NLM | |
650 | 7 | |a Q4516562YH |2 NLM | |
650 | 7 | |a Nucleotides |2 NLM | |
700 | 1 | |a Overdahl, Kirsten E |e verfasserin |4 aut | |
700 | 1 | |a Shannon, John P |e verfasserin |4 aut | |
700 | 1 | |a Hornick, Katherine M |e verfasserin |4 aut | |
700 | 1 | |a Jarmusch, Alan K |e verfasserin |4 aut | |
700 | 1 | |a Hickman, Heather D |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of virology |d 1967 |g 97(2023), 12 vom: 21. Dez., Seite e0127223 |w (DE-627)NLM000006866 |x 1098-5514 |7 nnns |
773 | 1 | 8 | |g volume:97 |g year:2023 |g number:12 |g day:21 |g month:12 |g pages:e0127223 |
856 | 4 | 0 | |u http://dx.doi.org/10.1128/jvi.01272-23 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 97 |j 2023 |e 12 |b 21 |c 12 |h e0127223 |